Human Milk Oligosaccharides Market Analysis and Segment Forecasts to 2022

Posted on Updated on

Global human milk oligosaccharides market is expected to reach USD 134.7 million by 2022, according to a new report by Grand View Research, Inc. The human milk oligosaccharides industry is expected to witness significant demand owing to increasing need from infant formula and functional food & beverage applications.

Numerous players have been investing for development of new technologies for commercial scale product manufacturing, thus augmenting growth. For instance, Inbiose N.V. uses fermentation process for commercial scale production of human milk oligosaccharides.

Rising concern regarding gut health coupled with increasing dairy industry is expected to augment product demand in dairy and pharmaceutical applications. Changing consumer lifestyles and shift towards nutritious food is expected to boost product need over the forecast period. In addition, issues related to infant malnutrition and mortality throughout the world is expected to augment product over the next seven years.

UK HMO market revenue by application, 2012 – 2022 (USD Thousand)


View summary of “Human Milk Oligosaccharides Market Analysis Report” @

Further key findings from the report suggest:

  • Infant Formula was the largest application, accounting for over 70% of global volume in 2014. High infant mortality rate coupled with increased need of the product for infants deprived of mother’s milk is expected to propel demand.
  • Functional food & beverages are expected to witness rise on account of growing awareness towards gut health. In addition, rapidly growing need for better healthcare services and nutritional food products in Asia Pacific and Latin America is expected to fuel growth over the next seven years. The segment is expected to grow at a CAGR of 17.9% from 2015 to 2022.
  • Europe was the dominant region in terms of volume, accounting for over 35.0% of the total share in 2014 primarily due to growing demand for prebiotic products. Europe human milk oligosaccharides demand is expected to grow at a significant rate owing to regulations promoting use of 2’FL and LNnT in infant formulas.
  • The global market is consolidated with limited players dominating the industry. Key companies present include Inbiose, Elicityl SA, Jennewein Biotechnologie, Glycom, Medolac Laboratories, ZuChem, and Glycosyn. These companies are extensively involved in R&D activities for the product. Moreover, some of the players including Glycom A/S are integrated across the value chain, where they produce the raw materials used in manufacturing of HMOs.

Request for free sample of “Human Milk Oligosaccharides Market Analysis Report” @


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s